Erudio Healtherudio.com
Clinical trial · no report yet · Phase not applicable
FAST-01 trial: what clinicians have said so far
Feasibility Study of FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases
- NCT04592887 ↗
- Completed
- Varian, a Siemens Healthineers Company
- Standard size, estimated: 151–300 verified statements once built
We haven't built an HCP commentary report on FAST-01 (symptomatic bone metastases; tests a strategy, not a drug) yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on FAST-01 so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Indexed so far | |
|---|---|
| 16 posts on X, typically up to 70 once built | |
| 1 YouTube video, typically up to 4 once built |
The trial
ClinicalTrials.gov- Official title
- Feasibility Study of FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases
- Phase
- Phase not applicable
- Status
- Completed
- Conditions
- Bone Metastasis
- Interventions
- FLASH Radiotherapy
- Arms
- FLASH radiotherapy for painful bone metastasis(-es) · Experimental
- Enrollment
- 10
- Primary outcomes
- Workflow Feasibility
- Workflow Feasibility
- Assessment of Radiation-related Toxicities That Are Possibly, Probably, or Definitely Related to FLASH Radiotherapy.
- Sponsor
- Varian, a Siemens Healthineers Company
- Start
- Nov 3, 2020
- Primary completion
- Mar 27, 2023
- Results posted
- Yes
- Registry record
- NCT04592887 · updated Jul 31, 2024
Publications
linked from the registry- Mascia AE, Daugherty EC, Zhang Y, Lee E, Xiao Z, Sertorio M, Woo J, Backus LR, McDonald JM, McCann C, Russell K, Levine L, Sharma RA, Khuntia D, Bradley JD, Simone CB 2nd, Perentesis JP, Breneman JC. Proton FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases: The FAST-01 Nonrandomized Trial. JAMA Oncol. 2023 Jan 1;9(1):62-69. doi: 10.1001/jamaoncol.2022.5843. PubMed 36273324
- Daugherty EC, Mascia A, Zhang Y, Lee E, Xiao Z, Sertorio M, Woo J, McCann C, Russell K, Levine L, Sharma R, Khuntia D, Bradley J, Simone CB 2nd, Perentesis J, Breneman J. FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases (FAST-01): Protocol for the First Prospective Feasibility Study. JMIR Res Protoc. 2023 Jan 5;12:e41812. doi: 10.2196/41812. PubMed 36206189
- Maity A, Koumenis C. Shining a FLASHlight on Ultrahigh Dose-Rate Radiation and Possible Late Toxicity. Clin Cancer Res. 2022 Sep 1;28(17):3636-3638. doi: 10.1158/1078-0432.CCR-22-1255. PubMed 35736814